Follow
Melissa Moore
Melissa Moore
St Vincent's Hospital Melbourne; University of Melbourne
Verified email at svha.org.au
Title
Cited by
Cited by
Year
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
L Lupinacci, C Martin, N Pilnik, ME Richardet, MS Varela, J Adams, ...
N Engl J Med 376 (25), 2415-2426, 2017
2465*2017
Inflammation and cancer: causes and consequences
MM Moore, W Chua, KA Charles, SJ Clarke
Clinical Pharmacology & Therapeutics 87 (4), 504-508, 2010
2752010
Activation of thermogenesis in brown adipose tissue and dysregulated lipid metabolism associated with cancer cachexia in mice
M Tsoli, M Moore, D Burg, A Painter, R Taylor, SH Lockie, N Turner, ...
Cancer research 72 (17), 4372-4382, 2012
1742012
Ethnic differences in drug metabolism and toxicity from chemotherapy
VH Phan, MM Moore, AJ McLachlan, M Piquette-Miller, H Xu, SJ Clarke
Expert opinion on drug metabolism & toxicology 5 (3), 243-257, 2009
1352009
A randomized controlled trial of a wearable technology‐based intervention for increasing moderate to vigorous physical activity and reducing sedentary behavior in breast cancer …
BM Lynch, NH Nguyen, MM Moore, MM Reeves, DE Rosenberg, T Boyle, ...
Cancer 125 (16), 2846-2855, 2019
1272019
A qualitative evaluation of breast cancer survivors’ acceptance of and preferences for consumer wearable technology activity trackers
NH Nguyen, NT Hadgraft, MM Moore, DE Rosenberg, C Lynch, ...
Supportive Care in Cancer 25 (11), 3375-3384, 2017
1132017
Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting
AMY Shum, T Mahendradatta, RJ Taylor, AB Painter, MM Moore, M Tsoli, ...
Aging (Albany NY) 4 (2), 133, 2012
992012
Use of inflammatory markers to guide cancer treatment
SJ Clarke, W Chua, M Moore, S Kao, V Phan, C Tan, K Charles, ...
Clinical Pharmacology & Therapeutics 90 (3), 475-478, 2011
852011
Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer
W Chua, PS Kho, MM Moore, KA Charles, SJ Clarke
Critical reviews in oncology/hematology 79 (3), 224-250, 2011
592011
Acute unilateral anterior uveitis and scleritis following a single infusion of zoledronate for metastatic breast cancer
MM Moore, JM Beith
Medical Journal of Australia 188 (6), 370, 2008
422008
A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group
MM Moore, M Stockler, R Lim, TSK Mok, M Millward, MJ Boyer
Cancer chemotherapy and pharmacology 66 (5), 845-850, 2010
382010
Maintenance of physical activity and sedentary behavior change, and physical activity and sedentary behavior change after an abridged intervention: Secondary outcomes from the …
BM Lynch, NH Nguyen, MM Moore, MM Reeves, DE Rosenberg, T Boyle, ...
Cancer 125 (16), 2856-2860, 2019
332019
The clinical relevance of pathologic subtypes in metastatic lung adenocarcinoma
TD Clay, H Do, V Sundararajan, MM Moore, M Conron, GM Wright, ...
Journal of thoracic oncology 9 (5), 654-663, 2014
292014
Linking physical activity to breast cancer via sex steroid hormones, part 2: The effect of sex steroid hormones on breast cancer risk
AE Drummond, CTV Swain, KA Brown, SC Dixon-Suen, L Boing, ...
Cancer Epidemiology and Prevention Biomarkers 31 (1), 28-37, 2022
242022
Effects of a wearable technology-based physical activity intervention on sleep quality in breast cancer survivors: The ACTIVATE Trial
NH Nguyen, JK Vallance, MP Buman, MM Moore, MM Reeves, ...
Journal of Cancer Survivorship 15 (2), 273-280, 2021
242021
Effects of the ACTIVity And TEchnology (ACTIVATE) intervention on health‐related quality of life and fatigue outcomes in breast cancer survivors
JK Vallance, NH Nguyen, MM Moore, MM Reeves, DE Rosenberg, ...
Psycho‐oncology 29 (1), 204-211, 2020
222020
Study design and methods for the ACTIVity And TEchnology (ACTIVATE) trial
BM Lynch, NH Nguyen, MM Reeves, MM Moore, DE Rosenberg, ...
Contemporary clinical trials 64, 112-117, 2018
202018
Assessment and relevance of enzyme‐linked immunosorbent assay for antibodies to Saccharomyces cerevisiae in Australian patients with inflammatory bowel disease
MM Moore, D Fabricatorian, WS Selby
Internal medicine journal 32 (7), 349-352, 2002
172002
Linking Physical Activity to Breast Cancer via Sex Hormones, Part 1: The Effect of Physical Activity on Sex Steroid Hormones
CTV Swain, AE Drummond, L Boing, RL Milne, DR English, KA Brown, ...
Cancer Epidemiology and Prevention Biomarkers 31 (1), 16-27, 2022
142022
Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations
TD Clay, PA Russell, H Do, V Sundararajan, M Conron, GM Wright, ...
Pathology 48 (1), 17-24, 2016
132016
The system can't perform the operation now. Try again later.
Articles 1–20